PointState Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-35,000
Closed -$3.59M 150
2021
Q4
$3.59M Buy
+35,000
New +$3.36M 0.06% 99
2018
Q1
Sell
-480,800
Closed -$21M 215
2017
Q4
$21M Buy
+480,800
New +$22.5M 0.2% 78

Other funds holding SYNH

PointState Capital's SYNH Position: Q1 2022 in Review

PointState Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2022, closing a stake of 35,000 shares — an estimated $3.59M sold.

PointState Capital first reported a position in SYNH in Q4 2017 and held it in 2 quarters. The position peaked at $21M in Q4 2017. 366 funds tracked by Wall St. Rank hold SYNH as of Q1 2022.

  • PointState Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • PointState Capital sold 35,000 Syneos Health, Inc. Class A Common Stock shares in Q1 2022, an estimated $3.59M.
  • PointState Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2017 and held it in 2 quarters.
  • PointState Capital's Syneos Health, Inc. Class A Common Stock position peaked at $21M in Q4 2017.
  • 366 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2022.

Based on PointState Capital's 13F filing for Q1 2022, filed 13 May 2022.